InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Klema Cathy. Director active across 1 company, notably OptimizeRx Corp. Cumulatively, 3 filings have been published. Activity tracked since 7 June 2024. The latest transaction was filed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条